The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C

FASEB Journal

Volumn 26, Issue 6, 2012, Pages 2446-2456

  Lorenzato, Annalisa ^a,c   Martino, Cosimo ^a,c   Dani, Nadia ^a,c   Oligschläger, Yvonne ^a,c   Ferrero, Anna Maria ^b   Biglia, Nicoletta ^b   Calogero, Raffaele ^d   Olivero, Martina ^a,c   Di Renzo, Maria Flavia ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

^c CANDIOLO CANCER INSTITUTE   (Italy)

^d ASO San Luigi Gonzaga   (Italy)

Author keywords

Hepatocyte growth factor; MET receptor; Nuclear import; Receptor tyrosine kinases

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; PROTEIN KINASE B; RAS ASSOCIATION DOMAIN FAMILY 1 PROTEIN; RAS PROTEIN; RNA; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL IMMORTALIZATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE PRODUCT; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NUCLEAR LOCALIZATION SIGNAL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DEPLETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL NUCLEUS; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CISPLATIN; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; OVARIAN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84861779221     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-195982     Document Type: Article

References (49)

1. Tulasne, D., and Foveau, B. (2008) The shadow of death on the MET tyrosine kinase receptor. Cell Death Differ. 15, 427-434 (Pubitemid 351267293)
2. Trusolino, L., Bertotti, A., and Comoglio, P. M. (2010) MET signalling: principles and functions in development, organ regeneration and cancer. Nat. Rev. Mol. Cell. Biol. 11, 834-848
3. Rasola, A., Anguissola, S., Ferrero, N., Gramaglia, D., Maffe, A., Maggiora, P., Comoglio, P. M., and Di Renzo, M. F. (2004) Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin. Cancer Res. 64, 1744-1750 (Pubitemid 38428697)
4. Bardella, C., Dettori, D., Olivero, M., Coltella, N., Mazzone, M., and Di Renzo, M. F. (2007) The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo. Clin. Cancer Res. 13, 2191-2198 (Pubitemid 46649889)
5. Birchmeier, C., Birchmeier, W., Gherardi, E., and Vande Woude, G. F. (2003) Met, metastasis, motility and more. Nat. Rev. Mol. Cell. Biol. 4, 915-925 (Pubitemid 37493640)
6. Coltella, N., Rasola, A., Nano, E., Bardella, C., Fassetta, M., Filigheddu, N., Graziani, A., Comoglio, P. M., and Di Renzo, M. F. (2006) p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int. J. Cancer 118, 2981-2990
7. Olivero, M., Ruggiero, T., Saviozzi, S., Rasola, A., Coltella, N., Crispi, S., Di Cunto, F., Calogero, R., and Di Renzo, M. F. (2006) Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin. Mol. Cancer Ther. 5, 1126-1135 (Pubitemid 43881304)
8. Peiro, G., Diebold, J., and Lohrs, U. (2002) CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Am. J. Clin. Pathol. 118, 922-929 (Pubitemid 37047833)
9. Brustmann, H. (2004) Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol. Oncol. 92, 268-276
10. Tsai, C. S., Chen, H. C., Tung, J. N., Tsou, S. S., Tsao, T. Y., Liao, C. F., Chen, Y. C., Yeh, C. Y., Yeh, K. T., and Jiang, M. C. (2010) Serum cellular apoptosis susceptibility protein is a potential prognostic marker for metastatic colorectal cancer. Am. J. Pathol. 176, 1619-1628
11. Bagnat, M., Navis, A., Herbstreith, S., Brand-Arzamendi, K., Curado, S., Gabriel, S., Mostov, K., Huisken, J., and Stainier, D. Y. (2010) Cse1l is a negative regulator of CFTR-dependent fluid secretion. Curr. Biol. 20, 1840-1845
12. Tai, C. J., Shen, S. C., Lee, W. R., Liao, C. F., Deng, W. P., Chiou, H. Y., Hsieh, C. I., Tung, J. N., Chen, C. S., Chiou, J. F., Li, L. T., Lin, C. Y., Hsu, C. H., and Jiang, M. C. (2010) Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp. Cell Res. 316, 2969-2981
13. Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R., and Gorlich, D. (1997) Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell 90, 1061-1071 (Pubitemid 27408520)
14. Tanaka, T., Ohkubo, S., Tatsuno, I., and Prives, C. (2007) hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell 130, 638-650 (Pubitemid 47268061)
15. Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., Sekido, Y., Latif, F., Milchgrub, S., Toyooka, S., Gazdar, A. F., Lerman, M. I., Zabarovsky, E., White, M., and Minna, J. D. (2001) Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl. Cancer Inst. 93, 691-699 (Pubitemid 32492810)
16. Michieli, P., Mazzone, M., Basilico, C., Cavassa, S., Sottile, A., Naldini, L., and Comoglio, P. M. (2004) Targeting the tumor and its microenvironment by a dual-function decoy Met receptor. Cancer Cell 6, 61-73 (Pubitemid 38903162)
17. Samouelian, V., Maugard, C. M., Jolicoeur, M., Bertrand, R., Arcand, S. L., Tonin, P. N., Provencher, D. M., and Mes-Masson, A. M. (2004) Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A. Cancer Chemother. Pharmacol. 54, 497-504 (Pubitemid 40022245)
18. Smith, J. A., Ngo, H., Martin, M. C., and Wolf, J. K. (2005) An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol. Oncol. 98, 141-145 (Pubitemid 40826431)
19. Roberts, D., Schick, J., Conway, S., Biade, S., Laub, P. B., Stevenson, J. P., Hamilton, T. C., O'Dwyer, P. J., and Johnson, S. W. (2005) Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br. J. Cancer 92, 1149-1158 (Pubitemid 40546683)
20. Royer, B., Guardiola, E., Polycarpe, E., Hoizey, G., Delroeux, D., Combe, M., Chaigneau, L., Samain, E., Chauffert, B., Heyd, B., Kantelip, J. P., and Pivot, X. (2005) Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding. Anticancer Drugs 16, 1009-1016 (Pubitemid 41416092)
21. Scherf, U., Pastan, I., Willingham, M. C., and Brinkmann, U. (1996) The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle. Proc. Natl. Acad. Sci. U. S. A. 93, 2670-2674 (Pubitemid 26114306)
22. Liao, C. F., Luo, S. F., Shen, T. Y., Lin, C. H., Chien, J. T., Du, S. Y., and Jiang, M. C. (2008) CSE1L/CAS, a microtubule-associated protein, inhibits taxol (paclitaxel)-induced apoptosis but enhances cancer cell apoptosis induced by various chemotherapeutic drugs. BMB. Rep. 41, 210-216
23. Ouellet, V., Guyot, M. C., Le Page, C., Filali-Mouhim, A., Lussier, C., Tonin, P. N., Provencher, D. M., and Mes-Masson, A. M. (2006) Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int. J. Cancer 119, 599-607 (Pubitemid 43955714)
24. Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M. B., Harpole, D., Lancaster, J. M., Berchuck, A., Olson, J. A., Jr., Marks, J. R., Dressman, H. K., West, M., and Nevins, J. R. (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357 (Pubitemid 43128862)
25. Behrens, P., Brinkmann, U., and Wellmann, A. (2003) CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 8, 39-44 (Pubitemid 36133136)
26. Kodiha, M., Tran, D., Morogan, A., Qian, C., and Stochaj, U. (2009) Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors. PLoS One 4, e8420
27. Vasudevan, K. M., Barbie, D. A., Davies, M. A., Rabinovsky, R., McNear, C. J., Kim, J. J., Hennessy, B. T., Tseng, H., Pochanard, P., Kim, S. Y., Dunn, I. F., Schinzel, A. C., Sandy, P., Hoersch, S., Sheng, Q., Gupta, P. B., Boehm, J. S., Reiling, J. H., Silver, S., Lu, Y., Stemke-Hale, K., Dutta, B., Joy, C., Sahin, A. A., Gonzalez-Angulo, A. M., Lluch, A., Rameh, L. E., Jacks, T., Root, D. E., Lander, E. S., Mills, G. B., Hahn, W. C., Sellers, W. R., and Garraway, L. A. (2009) AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16, 21-32
28. Calleros, L., Sanchez-Hernandez, I., Baquero, P., Toro, M. J., and Chiloeches, A. (2009) Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells. Carcinogenesis 30, 1670-1677
29. Xiao, Z., McGrew, J. T., Schroeder, A. J., and Fitzgerald-Hayes, M. (1993) CSE1 and CSE2, two new genes required for accurate mitotic chromosome segregation in Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 4691-4702 (Pubitemid 23220376)
30. Brinkmann, U., Brinkmann, E., Gallo, M., and Pastan, I. (1995) Cloning and characterization of a cellular apoptosis susceptibility gene, the human homologue to the yeast chromosome segregation gene CSE1. Proc. Natl. Acad. Sci. U. S. A. 92, 10427-10431
31. Bera, T. K., Bera, J., Brinkmann, U., Tessarollo, L., and Pastan, I. (2001) Cse1l is essential for early embryonic growth and development. Mol. Cell. Biol. 21, 7020-7024 (Pubitemid 32911261)
32. Tsao, T. Y., Tsai, C. S., Tung, J. N., Chen, S. L., Yue, C. H., Liao, C. F., Wang, C. C., and Jiang, M. C. (2009) Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol. Cell. Biochem. 327, 163-170
33. Liao, C. F., Luo, S. F., Li, L. T., Lin, C. Y., Chen, Y. C., and Jiang, M. C. (2008) CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J. Exp. Clin. Cancer Res. 27, 15
34. Yoon, S. O., Shin, S., Liu, Y., Ballif, B. A., Woo, M. S., Gygi, S. P., and Blenis, J. (2008) Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport. Mol. Cell 29, 362-375 (Pubitemid 351215938)
35. Courtney, K. D., Corcoran, R. B., and Engelman, J. A. (2010) The PI3K pathway as drug target in human cancer. J. Clin. Oncol. 28, 1075-1083
36. Yasuda, Y., Miyamoto, Y., Yamashiro, T., Asally, M., Masui, A., Wong, C., Loveland, K. L., and Yoneda, Y. (2012) Nuclear retention of importin alpha coordinates cell fate through changes in gene expression. EMBO J. 31, 83-94
37. Casolari, J. M., Brown, C. R., Komili, S., West, J., Hieronymus, H., and Silver, P. A. (2004) Genome-wide localization of the nuclear transport machinery couples transcriptional status and nuclear organization. Cell 117, 427-439 (Pubitemid 38610229)
38. Capelson, M., Liang, Y., Schulte, R., Mair, W., Wagner, U., and Hetzer, M. W. (2010) Chromatin-bound nuclear pore components regulate gene expression in higher eukaryotes. Cell 140, 372-383
39. Ogryzko, V. V., Brinkmann, E., Howard, B. H., Pastan, I., and Brinkmann, U. (1997) Antisense inhibition of CAS, the human homologue of the yeast chromosome segregation gene CSE1, interferes with mitosis in HeLa cells. Biochemistry 36, 9493-9500 (Pubitemid 27346989)
40. Donninger, H., Vos, M. D., and Clark, G. J. (2007) The RASSF1A tumor suppressor. J. Cell Sci. 120, 3163-3172 (Pubitemid 350018407)
41. Avruch, J., Xavier, R., Bardeesy, N., Zhang, X. F., Praskova, M., Zhou, D., and Xia, F. (2009) Rassf family of tumor suppressor polypeptides. J. Biol. Chem. 284, 11001-11005
42. Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., and Clark, G. J. (2000) Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J. Biol. Chem. 275, 35669-35672
43. Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., and Pfeifer, G. P. (2005) The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol. Histopathol. 20, 645-663 (Pubitemid 40468282)
44. Tommasi, S., Dammann, R., Zhang, Z., Wang, Y., Liu, L., Tsark, W. M., Wilczynski, S. P., Li, J., You, M., and Pfeifer, G. P. (2005) Tumor susceptibility of Rassf1a knockout mice. Cancer Res. 65, 92-98 (Pubitemid 40070799)
45. Song, M. S., Song, S. J., Kim, S. Y., Oh, H. J., and Lim, D. S. (2008) The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO J. 27, 1863-1874
46. Hamilton, G., Yee, K. S., Scrace, S., and O'Neill, E. (2009) ATM regulates a RASSF1A-dependent DNA damage response. Curr. Biol. 19, 2020-2025
47. Ratner, E., Lu, L., Boeke, M., Barnett, R., Nallur, S., Chin, L. J., Pelletier, C., Blitzblau, R., Tassi, R., Paranjape, T., Hui, P., Godwin, A. K., Yu, H., Risch, H., Rutherford, T., Schwartz, P., Santin, A., Matloff, E., Zelterman, D., Slack, F. J., and Weidhaas, J. B. (2010) A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res. 70, 6509-6515
48. Chin, L. J., Ratner, E., Leng, S., Zhai, R., Nallur, S., Babar, I., Muller, R. U., Straka, E., Su, L., Burki, E. A., Crowell, R. E., Patel, R., Kulkarni, T., Homer, R., Zelterman, D., Kidd, K. K., Zhu, Y., Christiani, D. C., Belinsky, S. A., Slack, F. J., and Weidhaas, J. B. (2008) A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res. 68, 8535-8540
49. Daskalos, A., Oleksiewicz, U., Filia, A., Nikolaidis, G., Xinarianos, G., Gosney, J. R., Malliri, A., Field, J. K., and Liloglou, T. (2011) UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 117, 1027-1037